• Academic Staff

      Professor Vehbi Erçolak
    Profile
    :
    Department
    :
    Faculty of Medicine/Department of Internal Medicine .
    Business Address
    :
    Adress .
    Phone
    :
    +90 -324-2410000 .
    Internal
    :
    dahili .
    Fax
    :
    +90 -000-0000000 .
    URL
    :
    VCARD
    :
    Created
    :
    2016-10-01 08:58:57 .
    Last Modification
    :
    2022-01-21 23:42:26 .
    Researcher ID :
    B-4820-2017
    Scopus ID :
    Orcid ID :
    0000-0003-1014-1694
    Scholar ID :
    h-index :
    Publons ID :
    Point :
    17579

    Degree Department/Program Institute Year
    LICENSE MEDICAL FACULTY CUKUROVA UNIVERSITY 1999
    MASTER'S DEGREE INTERNAL MEDICINE ONDOKUZ MAYIS UNIVERSITY 2007
    DOCTORATE MEDICAL ONCOLOGY CUKUROVA UNIVERSITY 2013

    Expertise in Medicine Thesis

    1. Evaluation of the quality of life in hemodialysis patients, Supervisor: Dr. Nurol Arık, Ondokuz Mayıs University, Others, Internal Medicine Department, Samsun, Turkey, 2007.

    Master Thesis

    1. PRAME expression in Hodgkin's lymphoma and its clinical significance, Supervisor: Dr. Semra Paydaş, Çukurova University, Others, Oncology Department, Adana, Turkey, 2013.

    Title Institute Year
    RESEARCH ASSISTANT ONDOKUZ MAYIS UNIVERSITY 2002-07-21 - 2007-05-15
    RESEARCH ASSISTANT CUKUROVA UNIVERSITY 2010-02-08 - 2013-02-20
    ASSISTANT PROFESSOR HARRAN UNIVERSITY 2014-10-20 - 2015-03-20
    ASSISTANT PROFESSOR MERSIN UNIVERSITY 2017-04-28 - Continue

    International - Covered by ULAKBIM 0
    2019
    1. ESER, K.; SEZER, E.; ERÇOLAK, V. . MERSIN UNIVERSITESI TIP FAKULTESI LOKMAN HEKIM TIP TARIHI VE FOLKLORIK TIP DERGISI, 2019, 9, 66-72. 0 + 0
    10.31020/mutftd.466992

    International - SCI/SCI-Expanded category 14675
    2023
    33. ERÇOLAK, V. . JAMA NETWORK OPEN, 2023, 6, -. 1000 + 0
    32. ESER, K.; SEZER, E.; ERÇOLAK, V.; İNAL, A. . MANAGED CARE AND HEALTHCARE COMMUNICATIONS, LLC, 2023, , -. 750 + 0
    10.37765/ajmc.2023.89234

    2022
    31. ERÇOLAK, V. . SPRINGER SCIENCE AND BUSINESS MEDIA LLC, 2022, 22, -. 1000 + 0
    10.1186/s12885-022-09624-y

    2021
    30. ERÇOLAK, V. . LEUKEMIA RESEARCH, 2021, 107, -. 1000 + 0
    10.1016/j.leukres.2021.106586

    29. ERÇOLAK, V. . LEUKEMIA RESEARCH, 2021, 102, -. 1000 + 0
    10.1016/j.leukres.2021.106519

    2020
    28. ESER, K.; SEZER, E.; ÖZTÜRK, B.; ÖNDER, A.; ERÇOLAK, V.; ORUÇ, Z.; İNAL, A. . UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2020, 4, 197-206. 400 + 0
    10.4999/uhod.204659

    27. KOÇ, Z.; ÖZCAN, P.; ERÇOLAK, V. . INDIAN JOURNAL OF CANCER, 2020, 0, 0-. 0 + 0
    2017
    26. PAYDAŞ, S.; DOĞAN, M.; ERÇOLAK, V.; SEYDAOĞLU, G. . ANNALS OF ONCOLOGY, 2017, 28, -. 750 + 0
    10.1093/annonc/mdx373.024

    2015
    25. Afsar, C.; Gunaldi, M.; Okuturlar, Y.; Gedikbaşı, A.; Tiken, E.; Kahraman, S.; Karaca, F.; Ercolak, V.; Karabulut, M. Paraoxonase-1 and arylesterase activities in patients with colorectal cancer. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , 2015, 8, 21599-21604. 100 + 0
    24. Afsar, C.; Karaca, F.; Günaldı, M.; Kara, O.; Erkisi, M.; Sahin, B.; Duman, B.; Paydas, S.; Ercolak, V. The effect of chemoradiotherapy on survival in locally advanced unresectable non-small cell lung cancer patients: experience from the southeast region of Turkey. ACTA MEDICA MEDITERRANEA, 2015, 31, 883-888. 100 + 0
    Publications_004.pdf

    23. Paydas, S.; Bağır, E.; Seydaoglu, G.; Ercolak, V.; Ergin, M. Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma. ANNALS OF HEMATOLOGY, 2015, 94, 1545-1552. 600 + 78
    http://dx.doi.org/10.1007/s00277-015-2403-2

    Publications_001.pdf


    Times Cited: 15
    22. PAYDAŞ, S.; KILIÇ BAĞIR, E.; SEYDAOĞLU, G.; ERÇOLAK, V.; ERGİN, M. . ANNALS OF HEMATOLOGY, 2015, 94, 1545-1552. 600 + 0
    10.1007/s00277-015-2403-2

    21. Karaca, F.; Afsar, C.; Günaldı, M.; Erkurt, E.; Ercolak, V.; Sertdemir, Y.; Paydas, S. Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8, 876-882. 400 + 5
    Publications_008.pdf


    Times Cited: 1
    20. Afsar, C.; Gunaldi, M.; Okuturlar, Y.; Gedikbasi, A.; Tiken, E.; Kahraman, S.; Karaca, F.; ERÇOLAK, V.; KARABULUT, M. . INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8, 21599-21604. 100 + 0
    19. Afsar, C.; Sahin, B.; Günaldı, M.; Kılıc, E.; Gümürdülü, D.; Burgut, H.; Erkisi, M.; Kara, O.; Paydas, S.; Karaca, F. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8, 9760-9771. 0 + 5
    Publications_010.pdf


    Times Cited: 1
    18. Ercolak, V.; Paydas, S.; Bagir, E.; Ergin, M.; Seydaoglu, G.; Celik, H.; Yavuz, B.; Tanriverdi, K.; Gunaldi, M.; Afsar, C. PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma. ACTA HAEMATOL, 2015, 134, 199-207. 650 + 0
    http://dx.doi.org/10.1159/000381533

    Publications_003.pdf

    17. Erçolak, V.; Şahin, B.; Günaldı, M.; Duman, B.; Afsar, C. Efficacy of paclitaxel in the treatment of Kaposi sarcoma.. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES., 2015, 19, 4095-4100. 900 + 5
    Publications_006.pdf


    Times Cited: 1
    2014
    16. Erçolak, V.; Kara, O.; Günaldı, M.; Afşar, Ç.; Duman, B.; Açıkalın, A.; Ergin, M.; Erdoğan, Ş. Bilateral Primary Adrenal Non-Hodgkin Lymphoma. TURKISH JOURNAL OF HAEMATOLOGY, 2014, 31, 205-206. 750 + 3
    http://dx.doi.org/10.4274/tjh.2013.0195

    Publications_017.pdf

    15. Afsar, C.; Günaldı, M.; Kum, P.; Sahin, B.; Erkisi, M.; Kara, O.; Paydas, S.; Duman, B.; Ercolak, V.; Karaca, F. Pancreatic Carcinoma, Thrombosis and Mean Platelet Volume: Single Center Experience from the Southeast Region of Turkey. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15, 9143-9146. 100 + 19
    Publications_012.pdf


    Times Cited: 2
    14. Gunaldi, M.; Erkısı, M.; Afsar, C.; Ercolak, V.; Duman, B.; Paydas, S.; Kara, O.; Sahin, B.; Tuli, A.; Secilmis, M. Evaluation of CYP2D6 Polymorphic Types and Their Effect on Tamoxifen Efficacy Among Turkish Tamoxifen Users with Breast Cancer. INTERNATIONAL JOURNAL OF HEMATOLOGY AND ONCOLOGY, 2014, 24, 157-162. 350 + 0
    Publications_014.pdf

    13. Ercolak, V.; Paydas, S.; Ergin, M.; Ates, B.; Duman, B.; Gunaldi, M.; Afsar, C. Abdominal actinomycosis with multiple myeloma: A case report. ONCOLOGY LETTERS., 2014, 8, 1876-1878. 400 + 6
    http://dx.doi.org/10.3892/ol.2014.2375

    Publications_015.pdf

    12. Günaldi, M.; Erkisi, M.; Afsar, Ç.; Erçolak, V.; Paydas, S.; Kara, I.; Sahin, B.; Gulec, U.; Secilmis, A. Evaluation of Endometrial Thickness and Bone Mineral Density Based on CYP2D6 Polymorphisms in Turkish Breast Cancer Patients Receiving Tamoxifen Treatment. PHARMACOLOGY., 2014, 94, 183-189. 400 + 0
    http://dx.doi.org/10.1159/000363304

    Publications_016.pdf

    11. Kocarslan, S.; Güldür, M.; Ekinci, T.; Ozardalı, İ.; Ercolak, V.; Yigit, E.; Köksal, M.; Ulas, T. Histopathological and immunohistochemical characteristics of Hodgkin’s Lymphomas from a single center in Southeastern Turkey. ACTA MEDICA MEDITERRANEA, 2014, 30, 1145-1150. 350 + 0
    Publications_011.pdf

    10. Ercolak, V.; Kara, O.; Duman, B.; Gunaldi, M.; Afsar, C.; Erdogan, S.; Totan, B. A case report of adult Wilms' tumour. CONTEMPORARY ONCOLOGY, 2014, 18, 1-3. 400 + 3
    file:///C:/Users/lenovo/Downloads/WOSI_Art_22255-10%20(1).pdf

    Publications_013.pdf

    2013
    9. Usul, Ç.; Paydaş, S.; Günaldı, M.; Duman, B.; Erçolak, V.; Zorludemir, S.; Açıkalın, A. Sweet Syndrome in a Patient with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Curious Lymphocyte/Neutrophil Fluctuations. THE TURKISH JOURNAL OF HEMATOLOGY, 2013, 30, 413-415. 200 + 11
    http://dx.doi.org/10.4274/Tjh.2012.0055

    Publications_018.pdf


    Times Cited: 1
    8. Günaldı, M.; Paydaş, S.; Usul Afşar, Ç.; Bozkurt Duman, B.; Erçolak, V.; Haksöyler, V. Carbamazepine and Multiple Myeloma: Possible Interaction. TURKISH JOURNAL OF HEMATOLOGY, 2013, 30, 83-84. 225 + 8
    http://dx.doi.org/10.4274/tjh.2012.0153

    Publications_019.pdf


    Times Cited: 1
    2012
    7. Gunaldi, M.; Kara, I.; Duman, B.; Ercolak, V. Primary Intracerebral Myeloid Sarcoma. ONKOLOGIE, 2012, 35, 694-697. 325 + 13
    http://dx.doi.org/10.1159/000343953

    Publications_020.pdf


    Times Cited: 2
    6. Duman, B.; Gunaldi, M.; Ercolak, V.; Afsar, C.; Sahin, B.; Erkisi, M.; Kara, O.; Paydas, S.; Gönlüsen, G.; Sertdemir, Y. Retrospective Analysis of 498 Primary Soft Tissue Sarcomas ina Single Turkish Centre. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13, 4125-4128. 450 + 13
    Publications_022.pdf


    Times Cited: 2
    5. Duman, B.; Paydas, S.; Tetiker, T.; Gunaldi, M.; Afsar, C.; Erçolak, V.; Haksöyler, V.; Dilli, M. Capecitabine-Induced Hypertriglyceridemia and Hyperglycemia: Two Cases. PHARMACOLOGY, 2012, 90, 212-215. 125 + 26
    http://dx.doi.org/10.1159/000342382

    Publications_023.pdf


    Times Cited: 4
    4. Duman, B.; Afsar, C.; Günaldı, M.; Sahin, B.; Kara, O.; Erkisi, M.; Ercolak, V. Retrospective Analysis of Neoadjuvant Chemotherapy for Breast Cancer in Turkish Patients. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13, 4119-4123. 200 + 18
    Publications_021.pdf


    Times Cited: 3
    2011
    3. Duman, B.; Kara, O.; Gunaldi, M.; Ercolak, V. Primary cutaneous small-cell carcinoma: a case report. MEDICAL ONCOLOGY, 2011, 28, 634-635. 650 + 5
    Publications_026.pdf


    Times Cited: 1
    2. Duman, B.; Kara, I.; Günaldi, M.; Ercolak, V. Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature. ARCHIVES OF GYNECOLOGY AND OBSTETRICS., 2011, 283, 1363-1368. 325 + 37
    http://dx.doi.org/10.1007/s00404-011-1845-6

    Publications_025.pdf


    Times Cited: 5
    2008
    1. Güler, N.; Tander, B.; Kısacık, B.; Utku, U.; Cevik, A.; Ercolak, V.; Ecemıs, G.; Ecemıs, O.; Aslan, R.; Cantürk, F. Low Dose Methotrexate Associated Pancytopenia in a Patient with Rheumatoid Arthritis. TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, 2008, 54, 79-81. 75 + 23
    Publications_028.pdf


    Times Cited: 1
    International - Covered by Other International Indexes 260
    2018
    4. Koç, Z.; Kara, P.; Eser, K.; Ercolak, V. Immature Heterotopic Ossification Mimicking Metastatic Progression of the Bone Diagnosed by F-18 Fluorodeoxyglucose (FDG) PET/CT. EC ORTHOPAEDICS, 2018, 8, 160-162. 65 + 0
    Publications_032.pdf

    2017
    3. Ozcan Kara, P.; Pinar Koc, Z.; Sezer, E.; Eser, K.; Ercolak, V. Malignant Peripheral Nerve Sheath Tumor Staging on PET-CT Imaging in a Patient with Neurofibromatosis Type I. MEDCRAVE GROUP, LLC, 2017, 3, 0-0. 50 + 0
    http://dx.doi.org/10.15406/ijrrt.2017.03.00070

    Publications_031.pdf

    2015
    2. Karaca, F.; Afsar, C.; Sert, F.; Izmir, S.; Ercolak, V.; Erkurt, E.; Tunalı, C. Palliative Radiotherapy for Spinal ExtramedullaryHematopoiesis in Thalassemia Major. INTERNATIONAL BLOOD RESEARCH & REVIEWS, 2015, 3, 124-129. 80 + 0
    Publications_007.pdf

    2012
    1. Gunaldi, M.; Bozkurt Duman, B.; Ercolak, V.; Usul Afsar, C.; Kara, I.; Sahin, B. Sorafenib Related Three Different Skin Toxicities: A Case Report. TURKISH JOURNAL OF DERMATOLOGY, 2012, 6, 17-20. 65 + 3
    http://dx.doi.org/10.5152/tdd.2012.04

    Publications_024.pdf

    International - Other 110
    2023
    2. KOÇ, Z.; ÖZCAN, P.; ERÇOLAK, V.; YUYUCU KARABULUT, Y. . MOLECULAR ONCOLOGIC IMAGING, 2023, 3, 7-12. 75 + 0
    2011
    1. Gunaldi, M.; Paydas, S.; Ercolak, V.; Duman, B.; Ergin, M. Hodgkin’s lymphoma of the surrenal: case report and review of the literature. OPEN JOURNAL OF ONCOLOGY, 2011, 1, 0-0. 35 + 0
    Publications_027.pdf

    International - ESCI kapsamındaki dergilerde yayımlanan tam makale 192
    2016
    2. Günaldı, M.; Duman, B.; Ercolak, V.; Afsar, C.; Paydas, S.; Erkisi, M.; Kara, O.; Sahin, B.; Gonlusen, G. Retrospective Analysis of 119 Osteosarcomas in a Single Centre Experience. JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7, 0-0. 150 + 0
    http://dx.doi.org/10.4328/JCAM.2689

    Publications_002.pdf

    2015
    1. Karaca, F.; Ercolak, V.; Afsar, C.; Gunaldi, M. Diffuse Large B Cell Lymphoma of the Breast. CUKUROVA MEDICAL JOURNAL, 2015, 40, 151-157. 42 + 0
    Publications_005.pdf

    International - publications.sections.8 130
    2022
    6. ÖZCAN, P.; KOÇ, Z.; YAVAN, G.; ERÇOLAK, V. . MOLECULAR ONCOLOGIC IMAGING, 2022, 2, 22-25. 0 + 0
    5. ÖZCAN, P.; SERDENGEÇTİ, M.; KOÇ, Z.; BALCI, Y.; TEK, M.; BOZLU, M.; AKBAY, E.; ERÇOLAK, V. . GEORG THIEME VERLAG KG, 2022, 21, -. 10 + 0
    10.1055/s-0042-1750331

    4. ÖZCAN, P.; KOÇ, Z.; ERÇOLAK, V.; SAĞLAM, Z.; YAVAN, G.; BOZLU, M.; TEK, M.; AKBAY, E. . MOLECULAR ONCOLOGIC IMAGING, 2022, 2, 15-24. 55 + 0
    2019
    3. KOÇ, Z.; ÖZCAN, P.; SEZER, E.; ERÇOLAK, V. . JOURNAL OF BONE AND SOFT TISSUE TUMORS, 2019, 5, 9-12. 65 + 0
    10.13107/jbst.2454–5473.341

    2018
    2. KOÇ, Z.; ÖZCAN KARA, P.; ESER, K.; ERÇOLAK, V. . EC ORTHOPAEDICS, 2018, , 160-162. 0 + 0
    2017
    1. ÖZCAN KARA, P.; KOÇ, Z.; SEZER, E.; ESEN, İ.; ERÇOLAK, V. . INTERNATIONAL JOURNAL OF RADIOLOGY RADIATION THERAPY, 2017, 3, 61-62. 0 + 0
    International - publications.sections.48 0
    2019
    1. KOÇ, Z.; ÖZCAN, P.; ERÇOLAK, V.; YALDIZ, M. . CLINICS ONCOLOGY, 2019, 2, 1010-. 0 + 0
    National - Covered by ULAKBIM 150
    2022
    1. ESER, K.; SEZER, E.; ERÇOLAK, V.; İNAL, A. . TURKIYE KLINIKLERI, 2022, 8, -. 150 + 0
    10.37047/jos.2021-87466

    National - Other 100
    2016
    1. Ercolak, V. Epidemiology and Risk Factors in Colorectal Cancer. KLINIK TIP AILE HEKIMLIGI, 2016, 8, 11-15. 100 + 0
    National - publications.sections.8 100
    2022
    1. KOÇ, Z.; ÖZCAN, P.; ERÇOLAK, V. . GALENOS YAYINEVI, 2022, 31, 60-62. 100 + 0
    10.4274/mirt.galenos.2020.78800

    International - Book Edited 0
    1. ERAS, N.; YURTSEVER, A.; ERÇOLAK, V. GASTROİNTESTİNAL SİSTEM KANSERLERİNDE GÜNCEL YAKLAŞIMLAR, ISBN: 978-625-8430-27-1, Akademisyen Kitabevi A.Ş., Number of print: , Total Printing Number: , Page, Turkish, , , 2021. 0
    International - Scientific Book (Excluded Thesis) 0
    1. ERÇOLAK, V.; ERDEM PALAZ, F. GASTROİNTESTİNAL SİSTEM KANSERLERİNDE GÜNCEL YAKLAŞIMLAR, ISBN: 978-625-8430-27-1, Akademisyen Kitabevi A.Ş., Number of print: 1, Total Printing Number: , 14 Page, Turkish, Mersin, Turkey, 2021. 0
    National - Scientific Book (Excluded Thesis) 0
    1. ERÇOLAK, V.; GÜNCAN, S. Türkiye Klinikleri Tıbbi Onkoloji - Özel Konular, Nadir Tümörler, ISBN: 1300-0292, Türkiye Klinikleri, Number of print: 11, Total Printing Number: , 166 Page, Turkish, , Turkey, 2020. 0

    International - Abstract - Oral 70

    1. ESER, K.; SEZER, E.; ERÇOLAK, V.; SEZER, K.; ÇITAK, E., Effectiveness of vandetanib treatment in medullary thyroid cancer. single center experience. 2.ulusal immunoterapi ve onkoloji kongresi, 2018-10-31, 2018-11-04, Antalya, Turkey, . 70

    International - Abstract - Poster 197

    7. KOÇ, Z.; ÖZCAN, P.; ERÇOLAK, V.; KARABULUT, Y., European Association of Nuclear Medicine October 20-23, 2021 Virtual. Annual Congress of the European Association of Nuclear Medicine 2021, 2021-10-20, , , , . 37

    6. SEZER, E.; ESER, K.; ERÇOLAK, V.; yusuf, a.; ÖZTÜRK, B., The prognostic values of tumor characteristics and clinical factors of neuroendocrine tumors: Two centers experience. ESMO 2018, 2018-10-19, 2018-10-23, BARCELONA, Spain, . 35

    5. PAYDAŞ, S.; DOĞAN, M.; ERÇOLAK, V.; SEYDAOĞLU, G., International prognostic scores (IPS-7, IPS-3 and IPS-3 new) for prediction of FFS and OS in cases with Hodgkin Lymphoma. Which is more practical and accurate?. 42nd ESMO Congress, 2017-09-08, 2017-09-12, , , . 37

    4. PAYDAŞ, S.; DOĞAN, M.; ERÇOLAK, V.; SEYDAOĞLU, G., International prognostic scores (IPS-7, IPS-3 and IPS-3 new) for prediction of FFS and OS in cases with Hodgkin Lymphoma. Which is more practical and accurate?. 42nd ESMO Congress, 2017-09-08, 2017-09-12, MADRİD, Spain, 2017. 37

    3. Afsar, C.; Sahin, B.; Gumurdulu, D.; Bagır, E.; Burgut, R.; Erkisi, M.; Kara, O., Evaluation of fibroblast growth factor receptor 1 (FGFR1), fibroblast growth factor 2 (FGFR2), phosphatidyl inositol 3 phosphate kinase (IP3K) expression and their clinical, prognostic significance in early and advanced stage of squamous cell carcinoma of the lung. 39th ESMO Congress, 2014-09-26, 2014-09-30, MADRID, Turkey, 2014. 5

    2. Gunaldi, M.; Erkisi, M.; Afsar, C.; Ercolak, V.; Paydas, S.; Kara, O.; Sahin, B., The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment. ASCO 50. ANNUAL MEETING SCIENCE SOCIETY, 2014-05-30, 2014-06-03, CHIGAGO, United States of America, 2014. 20

    1. Paydas, S.; Bagir, E.; Ergin, M.; Duman, B.; Ercolak, V., Programmed death-1 (PD-1) and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma. ASCO 50. ANNUAL MEETING SCIENCE SOCIETY, 2014-05-30, 2014-06-03, CHIGAGO, United States of America, 2014. 25

    National - Full text - Oral 100

    1. ERÇOLAK, V., Hodgkin Lenfoma olgularında uluslararası prognostik skor (IPS)-7 ve IPS-3 arasındaki korelasyon. 22. ULUSAL KANSER KONGRESİ, 2017-04-19, 2017-04-23, , Turkey, . 100

    National - Abstract - Oral 135

    5. OKTAY, A.; ESER, K.; TENEKECİ, G.; ERÇOLAK, V.; SEZER, E.; DEMİR, Y.; ÜNAL, Ş., S-062 Bazal hücreli kanser tedavisinde oral kemoterapötik vismodegib kullanımı hakkında tecrübelerimiz. Türk Plastik, Rekonstrüktif ve Estetik Cerrahi Derneği, 40. Ulusal Kurultayı, 2018-10-17, 2018-10-21, Antalya, Turkey, . 25

    4. OKTAY, A.; ESER, K.; TENEKECİ, G.; ERÇOLAK, V.; SEZER, E.; DEMİR, Y.; ÜNAL, Ş., S-062 Bazal Hücreli Kanser Tedavisinde Oral Kemoterapatik Vismodegib Kullanımı Hakkında Tecrübelerimiz. 40.Ulusal Türk Plastik Rekonstrüktif ve Estetik Cerrahi Derneği Kurultayı, 2018-10-17, 2018-10-21, Antalya, Turkey, . 25

    3. ERÇOLAK, V., Hodgkin Lenfoma olgularında uluslararası prognostik skor (IPS)-7 ve IPS-3 arasındaki korelasyon. 22.ULUSAL KANSER KONGRESİ, 2017-04-19, 2017-04-23, ANTALYA, Turkey, 2017. 50

    2. Afsar, C.; Kum, P.; Sahin, B.; Duman, B.; Gunaldi, M.; Ercolak, V.; Paydas, S., ÇUKUROVA ÜNIVERSITESI TIP FAKÜLTESI'NDE TANI KONULMUS PANKREAS KANSERLI HASTALARIMIZIN RETROSPEKTIF OLARAK DEGERLENDIRILMESI VE DERIN VEN TROMBOZU ILE METASTAZ YERI VE ORTALAMA TROMBOSIT HACMI ARASINDAKI ILISKININ INCELENMESI. 20. Ulusal Kanser Kongresi, 2013-04-19, 2013-04-23, Antalya, Turkey, 2013. 10

    1. Gunaldi, M.; Duman, B.; Ercolak, V.; Sahin, B.; Erkisi, M.; Paydas, S.; Kara, O., Osteosarkoma : Tek Merkez Verisi. . 19. Ulusal Kanser Kongresi, 2011-04-20, 2011-04-24, Antalya, Turkey, 2011. 25

    National - Abstract - Poster 523

    44. SEZER, E.; ESER, K.; ÖNDER, A.; ÖZTÜRK, B.; ERÇOLAK, V.; ORUÇ, Z., The prognostic and predictive value of primary tumor sidedness in the mCRC p. ESMO 20th World Congress on Gastrointestinal Cancer 20–23 June 2018, Barcelona, Spain, 2018-10-19, , BARCELONA, Spain, . 11

    43. Ercolak, V., PREOPERATIF MEME KANSERINDE PET-CT ILE TÜMÖR BELIRTEÇLERI ARASINDA KORELASYON. 6. Türk Tıbbi Onkoloji Kongresi, 2016-03-23, 2016-03-27, Antalya, Turkey, 2016. 25

    42. Mirili, C.; Paydas, S.; Ercolak, V.; Balli, T.; Binokay, F.; Gokcay, S.; Ogul, A., A CASE REPORT: PREPHASE THERAPY FOR AN ELDERLY PATIENT WITH DIFFUSE LARGE B CELL LYPMHOMA WITH HIGH TUMOR BURDEN: EXELLENT EFFICACY WITHOUT TOXICITY. 6. Türk Tıbbi Onkoloji Kongresi, 2016-03-23, 2016-03-27, Antalya, Turkey, 2016. 15

    41. Ercolak, V.; Sevinc, A.; Aydın, F.; Bakır, K., MALIGN METASTATIK SPIRADENOKARSINOMA: BIR VAKA RAPORU VE LITERATÜRÜN GÖZDEN GEÇIRILMESI. 21. ULUSAL KANSER KONGRESI, 2015-04-22, 2015-04-26, Antalya, Turkey, 2015. 23

    40. Paydas, S.; Bagir, E.; Ergin, M.; Ercolak, V.; Seydaoglu, G., HODGKIN LENFOMADA PROGRAMLI ÖLÜM-1 (PD-1), PROGRAMLI ÖLÜM LIGAND- 1 (PDL- 1) VE EBV KODLAYAN RNA (EBER) EKSPRESYONU. 40. ULUSAL HEMATOLOJI KONGRESI, 2014-10-22, 2014-10-25, Antalya, Turkey, 2014. 15

    39. Ercolak, V.; Paydas, S.; Seydaoglu, G.; Gunaldi, M.; Afsar, C.; Duman, B., HODGKIN LENFOMA OLGULARINDA RETROSPEKTIF DEGERLENDIRME ÇUKUROVA ÜNIVERSITESI DENEYIMI. 5. Türk Tıbbi Onkoloji Kongresi, 2014-03-19, 2014-03-23, Antalya, Turkey, 2014. 21

    38. Gunaldi, M.; Afsar, C.; Ercolak, V.; Erkisi, M.; Paydas, S.; Kara, O.; Sahin, B., ERKEN EVRE MEME KANSERLI HASTALARDA ADJUVANT TAMOKSIFENIN SERUM LIPID DÜZEYLERINE ETKISI. 5. Türk Tıbbi Onkoloji Kongresi, 2014-03-19, 2014-03-23, Antalya, Turkey, 2014. 15

    37. Afsar, C.; Kum, P.; Gunaldi, M.; Duman, B.; Ercolak, V.; Sahin, B.; Kara, O., ÖZOFAGUS KANSERLI 64 HASTA. 10. ULUSAL TIBBI ONKOLOJI KONGRESI, 2013-09-11, 2013-09-15, Muğla, Turkey, 2013. 10

    36. Kum, P.; Sahin, B.; Afsar, C.; Gunaldi, M.; Ercolak, V., AKCIGER KANSERLI 2311 HASTANIN ÖZELLIKLERI. 20. Ulusal Kanser Kongresi, 2013-04-19, 2013-04-23, Antalya, Turkey, 2013. 12

    35. Kum, P.; Sahin, B.; Afsar, C.; Gunaldi, M.; Ercolak, V., TANI ANINDAKI ILERI EVRE OLAN 215 HASTANIN ÖZELLIKLERI. 20. Ulusal Kanser Kongresi, 2013-04-19, 2013-04-23, Antalya, Turkey, 2013. 12

    34. Kum, P.; Sahin, B.; Afsar, C.; Gunaldi, M.; Ercolak, V.; Duman, B., KÜÇÜK HÜCRELI AKCIGER KANSERLI 382 OLGUNUN DEMOGRAFIK ÖZELLIKLERI. 20. Ulusal Kanser Kongresi, 2013-04-19, 2013-04-23, Antalya, Turkey, 2013. 11

    33. Kum, P.; Sahin, B.; Afsar, C.; Gunaldi, M.; Ercolak, V., MIDE KANSERLI 107 HASTA VE ÖZELLIKLERI. 20. Ulusal Kanser Kongresi, 2013-04-19, 2013-04-23, Antalya, Turkey, 2013. 12

    32. Gunaldi, M.; Kara, O.; Afsar, C.; Ercolak, V.; Duman, B., AKROMEGALIYE ESLIK EDEN MALIGN MEZENKIMAL TÜMÖR. 9. ULUSAL TIBBI ONKOLOJI KONGRESI, 2012-09-12, 2012-09-16, Magosa, TRNC, 2012. 15

    31. Bayram, E.; Paydas, S.; Zorludemir, S.; Dogmus, A.; Aciklalin, A.; Afsar, C.; Gunaldi, M., Gemcitabine iliskli Dress Sendromu bir olgu nedeniyle. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 2

    30. Afsar, C.; Paydas, S.; Gonlusen, G.; Gunaldi, M.; Ercolak, V.; Duman, B., GENÇ BIR ERKEK HASTADA YUMUSAK DOKU MALIGN MYOEPITELYOMASI. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 11

    29. Gunaldi, M.; Paydas, S.; Afsar, C.; Ercolak, V.; Duman, B.; Doran, F., TUBEROSKLEROZ VE MALIGN MELANOM BIRLIKTELIGI. 4.Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 13

    28. Afsar, C.; Sahin, B.; Kara, O.; Erkisi, M.; Duman, B.; Gunaldi, M.; Ercolak, V., Nüks Glioblastome Multiformeli bir hastada Irinotekan Bevacızumab Fenitoin ilaç etkilesimi olarak Hepatotoksisite. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 2

    27. Duman, B.; Paydas, S.; Gunaldi, M.; Afsar, C.; Ercolak, V.; Tetiker, T.; Dilli, M., Kapesitabin iliskili ciddi hipertrigliseridemi iki olgu sunumu.. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 8

    26. Gunaldi, M.; Sahin, B.; Duman, B.; Ercolak, V.; Afsar, C., Bevacizumab çene osteonekrozu için bir risk faktörü müdür?. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 15

    25. Gunaldi, M.; Erkisi, M.; Afsar, C.; Duman, B.; Ercolak, V., RICHTER SENDROMU. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 12

    24. Afsar, C.; Paydas, S.; Gumurdulu, D.; Gunaldi, M.; Ercolak, V., AKCIGER SARKOMATOID KARSINOMUNUN BIR ALT TIPI PULMONER BLASTOM. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 12

    23. Afsar, C.; Kara, O.; Sakman, G.; Parsak, C.; Gumurdulu, D.; Duman, B.; Ercolak, V., BILATERAL OVER METASTAZI ILE TANI KONAN PRIMER APPENDIKS ADENOKARSINOMU. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 2

    22. Gunaldi, M.; Duman, B.; Ercolak, V.; Afsar, C.; Paydas, S.; Kara, O.; Erkisi, M., Trastuzumab iliskili kardiyotoksisiteye Epirubisin ve Doxorubisin katkısının arastırılması. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 13

    21. Afsar, C.; Erkisi, M.; Uguz, A.; Ates, B.; Acıkalın, A.; Gunaldi, M.; Ercolak, V., Larenks epidermoid karsinom ve malign epidermoid karsinom ve malign fibröz histiositom birlikteligi larenkste bir sarkomatoid karsinom. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 5

    20. Gunaldi, M.; Erkisi, M.; Afsar, C.; Duman, B.; Ercolak, V., AKCIGER KARSINOMLU HASTADA ?-2 GLOBULIN PIKI. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 12

    19. Duman, B.; Sahin, B.; Ergin, M.; Gunaldi, M.; Afsar, C.; Ercolak, V.; Zorludemir, S., HER2 pozitif meme kanserinde PTEN AKT MAPK P53 ekspresyonunun neoadjuvan tedavi sonrası patolojik tam yanıta ve sagkalıma etkisi. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 6

    18. Duman, B.; Erkisi, M.; Sahin, B.; Kara, O.; Gunaldi, M.; Afsar, C.; Ercolak, V., UNILATERAL PLEVRAL EFÜZYONLA PROGRESE MULTIPLE MYELOMA OLGUSU. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 5

    17. Afsar, C.; Paydas, S.; Gumurdulu, D.; Gunaldi, M.; Ercolak, V.; Açikalin, A., MEME KANSERLI BIR VAKADA TTF-1 POZITIFLIGI. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 11

    16. Duman, B.; Sahin, B.; Erkisi, M.; Paydas, S.; Kara, O.; Afsar, C.; Gunaldi, M., METASTATIK RENAL HÜCRELI KARSINOMDA SITOREDÜKTIF NEFREKTOMININ SAGKALIM ÜZERINE ETKISI. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 2

    15. Afsar, C.; Kara, O.; Gunaldi, M.; Duman, B.; Ercolak, V.; Parsak, C.; Sakman, G., MUIR TORRE SENDROMU. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 7

    14. Ercolak, V.; Kara, O.; Gunaldi, M.; Afsar, C.; Erdogan, S.; Ergin, M.; Acıkalın, A., BILATERAL PRIMER ADRENAL NON-HODGKIN LENFOMA. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 20

    13. Ercolak, V.; Kara, O.; Afsar, C.; Gunaldi, M.; Erdogan, S.; Ates, B., ERISKIN WILMS TÜMÖRÜ. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 21

    12. Afsar, C.; Kara, O.; Gunaldi, M.; Duman, B.; Ercolak, V., Hematolojik malignitelerde endometrium over ve serviks tutulumu. 4. Tıbbi Onkoloji Kongresi, 2012-03-21, 2012-03-25, Antalya, Turkey, 2012. 12

    11. Ercolak, V.; Sahin, B.; Paydas, S.; Kara, O.; Erkisi, M.; Duman, B.; Gunaldi, M., Kaposi Sarkomunda Paclitaksel Etkinligi. 19. Ulusal Kanser Kongresi, 2011-04-20, 2011-04-24, Antalya, Turkey, 2011. 18

    10. Duman, B.; Erkisi, M.; Sahin, B.; Kara, O.; Gunaldi, M.; Ercolak, V.; Afsar, C., Primer Tanıdan 14 Yıl Sonra Over Metastazı Ile Prezente Olan Meme Karsinomu Olgusu. 19.Ulusal Kanser Kongresi, 2011-04-20, 2011-04-24, Antalya, Turkey, 2011. 7

    9. Gunaldi, M.; Kara, O.; Duman, B.; Ercolak, V., Intrakranyal Granulositik Sarkom. 19.Ulusal Kanser Kongresi, 2011-04-20, 2011-04-24, Antalya, Turkey, 2011. 16

    8. Duman, B.; Sahin, B.; Erkisi, M.; Paydas, S.; Kara, O.; Gunaldi, M.; Ercolak, V., Yumusak Doku Sarkomlarının Retrospektif Analizi: Tek Merkez Deneyimi. 19.Ulusal Kanser Kongresi, 2011-04-20, 2011-04-24, Antalya, Turkey, 2011. 2

    7. Gunaldi, M.; Sahin, B.; Duman, B.; Ercolak, V.; Afsar, C.; Kara, O., Radyoaktif Iyot Tedavisine Dirençli Metastatik Tiroid Foliküler Karsinomunda: Sorafenib; Olgu Sunumu. 19. Ulusal Kanser Kongresi, 2011-04-20, 2011-04-24, Antalya, Turkey, 2011. 13

    6. Duman, B.; Sahin, B.; Erkisi, M.; Kara, O.; Gunaldi, M.; Ercolak, V.; Afsar, C., Meme Karsinomunda Neoadjuvant Kemoterapi Rejimi Doz Dese Mi Olmalıdır?. . 19. Ulusal Kanser Kongresi, 2011-04-20, 2011-04-24, Antalya, Turkey, 2011. 7

    5. Gunaldi, M.; Sahin, B.; Erkisi, M.; Kara, O.; Afsar, C.; Duman, B.; Ercolak, V., PET-BT'de Yalancı Negatiflik: Olgu Sunumu. 19. Ulusal Kanser Kongresi, 2011-04-20, 2011-04-24, Antalya, Turkey, 2011. 5

    4. Duman, B.; Sahin, B.; Erkisi, M.; Kara, O.; Ercolak, V.; Gunaldi, M.; Afsar, C., Meme Tümör Dokusunda Neoadjuvant Tedavi Öncesi ve Sonrası ER, PR, HER2 Ekspresyonları Arasında Diskordans Var Mıdır?. 19.Ulusal Kanser Kongresi, 2011-04-20, 2011-04-24, Antalya, Turkey, 2011. 8

    3. Afsar, C.; Sahin, B.; Duman, B.; Ercolak, V.; Gunaldi, M., Temsirolimus Ile Tedavi Edilen Berrak Hücreli Dısı Renal Karsinomlu Bir Hastada Gelisen Böbrek Yetmezliginin Yönetimi: Olgu Sunumu. 19. Ulusal Kanser Kongresi, 2011-04-20, 2011-04-24, Antalya, Turkey, 2011. 15

    2. Ercolak, V.; Gunaldi, M.; Sahin, B., MEME KANSERINDE LOKOREJYONEL REKÜRRENS OLGU SUNUMU. III.TIBBI ONKOLOJI KONGRESI, 2010-03-24, 2010-03-28, Antalya, Turkey, 2010. 25

    1. Gunaldi, M.; Sahin, B.; Paydas, S.; Kara, O.; Erkisi, M.; Duman, B.; Ercolak, V., TRASTUSUMAB VE KARDIOTOKSISITE:RETROSPEKTIF BIR ÇALISMA. III.TIBBI ONKOLOJI KONGRESI, 2010-03-24, 2010-03-28, Antalya, Turkey, 2010. 5

    National - Abstract - Davetli 0

    1. Ercolak, V., NEFESI DARALAN KANSER HASTASI. 6. ÇUKUROVA IÇ HASTALIKLARI GÜNLERI, 2011-06-10, 2011-06-10, Adana, Turkey, 2011. 0

    National - Manager 100

    1. Relationship of WBP-2 protein with prognosis and clinical parameters in Head and Neck Tumors, BAP, Project Number: 2021-2-TP3-4489, 21340 TL, Manager, Continue... 100

    National - Researcher 100

    2. The diagnostic efficiency of Ga-68 FAPI PET/CT in primary brain tumors, BAP, Project Number: 2023-1-AP4-4833, 59466 TL, Researcher, Continue... 50

    1. Determining the Efficacy of Different Types and Subtypes of Immune System Cells as Personalized Cancer Immunotherapy Agents by Utilizing from In Vitro and Ex Vivo Methods, BAP, Project Number: 2021-1-AP5-4286, 430000 TL, Researcher, Continue... 50

    International Journal [Year, Count] 4
    1. JOURNAL OF ONCOLOGICAL SCIENCE , [ 2018 : 1 ] . 4
    National Journal [Year, Count] 1
    1. RESPIRATORY CASE REPORTS , [ 2017 : 1 ] . 1

    National 50
    1. , 2012-03-25, Antalya, Turkey. 25
    2. , 2013-04-23, Antalya, Turkey. 0
    3. , 2014-10-25, Antalya, Turkey. 25
    4. , 2016-03-25, Antalya, Turkey. 0
    5. , 2017-11-01, Antalya, Turkey. 0
    6. , , , Turkey. 0
    7. , , , Turkey. 0
    8. , , , Turkey. 0

    1. , Member No: 0, Turkey, 2010-02-16-Continue.
    Getting Information
    Strategic Planning
    Bologna Process
    European University Association
    MEU Radio
    Presidential Communication Center
    Osym Provincial Exam Coordinator
    Academic Calendar
    Corporate Internal and External Evaluation Reports
    Graduate Communication
    Green Campus
    Ad Portal

    GENERAL

    Contact

    "A World University In The Light of Science and Modernity"